LC-MS in Drug Analysis

[1]  M. Montgomery,et al.  A fast method for screening and/or quantitation of tetrahydrocannabinol and metabolites in urine by automated SPE/LC/MS/MS , 2010, Analytical and bioanalytical chemistry.

[2]  Ó. Pozo,et al.  Direct quantification of 11-nor-Delta(9)-tetrahydrocannabinol-9-carboxylic acid in urine by liquid chromatography/tandem mass spectrometry in relation to doping control analysis. , 2010, Rapid communications in mass spectrometry : RCM.

[3]  J. Hackett,et al.  Solid-phase extraction and analysis of THC and carboxy-THC from whole blood using a novel fluorinated solid-phase extraction sorbent and fast liquid chromatography-tandem mass spectrometry. , 2009, Journal of analytical toxicology.

[4]  K. Klette,et al.  Automated solid-phase extraction-liquid chromatography-tandem mass spectrometry analysis of 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in human urine specimens: application to a high-throughput urine analysis laboratory. , 2009, Journal of analytical toxicology.

[5]  M. Lebeau,et al.  A semi-automated solid-phase extraction liquid chromatography/tandem mass spectrometry method for the analysis of tetrahydrocannabinol and metabolites in whole blood. , 2009, Rapid communications in mass spectrometry : RCM.

[6]  N. Samyn,et al.  On-line solid-phase extraction combined with liquid chromatography-tandem mass spectrometry for high throughput analysis of 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in urine. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[7]  C. Moore,et al.  Quantitation of tetrahydrocannabinol in hair using immunoassay and liquid chromatography with tandem mass spectrometric detection. , 2009, Drug testing and analysis.

[8]  N. Samyn,et al.  Simultaneous analysis of THC and its metabolites in blood using liquid chromatography-tandem mass spectrometry. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[9]  C. Moore,et al.  Tetrahydrocannabinol and two of its metabolites in whole blood using liquid chromatography-tandem mass spectrometry. , 2008, Journal of analytical toxicology.

[10]  R. Kronstrand,et al.  Accurate identification and quantification of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid in urine drug testing: evaluation of a direct high efficiency liquid chromatographic-mass spectrometric method. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[11]  B. Ludes,et al.  Determination of cannabinoids in whole blood by UPLC-MS-MS. , 2008, Journal of analytical toxicology.

[12]  A. Verstraete,et al.  Validated method for the simultaneous determination of Delta9-THC and Delta9-THC-COOH in oral fluid, urine and whole blood using solid-phase extraction and liquid chromatography-mass spectrometry with electrospray ionization. , 2007, Forensic science international.

[13]  J. Drewe,et al.  Development of a LC/MS/MS method for the analysis of cannabinoids in human EDTA-plasma and urine after small doses of Cannabis sativa extracts. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[14]  D. Crouch,et al.  A validated method for the detection of Delta 9-tetrahydrocannabinol and 11-nor-9-carboxy- Delta 9-tetrahydrocannabinol in oral fluid samples by liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry. , 2007, Journal of analytical toxicology.

[15]  W. Vaes,et al.  Determination of cannabinoids in cannabis products using liquid chromatography-ion trap mass spectrometry. , 2004, Journal of chromatography. A.

[16]  M. Concheiro,et al.  Development and validation of a method for the quantitation of Δ9tetrahydrocannabinol in oral fluid by liquid chromatography electrospray–mass-spectrometry , 2004 .

[17]  A. Stinchcomb,et al.  Liquid chromatographic-mass spectrometric quantitation of Delta9-tetrahydrocannabinol and two metabolites in pharmacokinetic study plasma samples. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[18]  G. Skopp,et al.  Stability of 11-nor-delta(9)-carboxy-tetrahydrocannabinol glucuronide in plasma and urine assessed by liquid chromatography-tandem mass spectrometry. , 2002, Clinical chemistry.

[19]  S. Pollak,et al.  Fast confirmation of 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol (THC-COOH) in urine by LC/MS/MS using negative atmospheric-pressure chemical ionisation (APCI). , 2001, Forensic science international.

[20]  A. Stinchcomb,et al.  LC-MS method for the estimation of delta8-THC and 11-nor-delta8-THC-9-COOH in plasma. , 2005, Journal of pharmaceutical and biomedical analysis.

[21]  N. Samyn,et al.  Quantitative analysis of delta9-tetrahydrocannabinol in preserved oral fluid by liquid chromatography-tandem mass spectrometry. , 2005, Journal of chromatography. A.

[22]  W. Weinmann,et al.  Simultaneous determination of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy- Delta9-tetrahydrocannabinol in human plasma by high-performance liquid chromatography/tandem mass spectrometry. , 2004, Journal of mass spectrometry : JMS.

[23]  R. Foltz,et al.  Quantitative measurement of delta 9-tetrahydrocannabinol and two major metabolites in physiological specimens using capillary column gas chromatography negative ion chemical ionization mass spectrometry. , 1983, Biomedical mass spectrometry.